David C. Hui
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Tuberculosis Infection: Diagnosis and Management.
Journal: Cold Spring Harbor perspectives in medicine
Published: May 26, 2026
Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.
Journal: NEJM evidence
Published: March 24, 2026
Global tuberculosis response off track: urgent priorities to end the world's top infectious killer.
Journal: Lancet (London, England)
Published: November 23, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID diabetes risk among an older adult cohort: a target trial emulation study.
Journal: BMC medicine
Published: November 19, 2025
Use of AI in general practice.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: November 06, 2025
Host Immunomodulatory Interventions in Severe Influenza.
Journal: The Journal of infectious diseases
Published: October 16, 2025
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025
Young and promising
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: August 22, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study.
Journal: Nature communications
Published: May 15, 2025
Association between early SARS-CoV-2 viral rebound and post-COVID conditions among immunocompromised patients: cohort study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: April 09, 2025
Revisiting oral antivirals for COVID-19 in the hospital setting.
Journal: The Lancet. Infectious diseases
Published: March 10, 2025
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation.
Journal: Emerging microbes & infections
Published: February 18, 2025
Last Updated: 09/26/2026